Cardiac Protective Role of Heat Shock Protein 27 in the Stress Induced by Drugs of Abuse.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 May 2020
Historique:
received: 10 03 2020
revised: 16 05 2020
accepted: 19 05 2020
entrez: 28 5 2020
pubmed: 28 5 2020
medline: 17 2 2021
Statut: epublish

Résumé

Heat shock proteins (HSP) are induced after different stress situations. Some of these proteins, particularly HSP-27, function as markers to indicate cellular stress or damage and protect the heart during addictive processes. Morphine withdrawal induces an enhancement of sympathetic activity in parallel with an increased HSP-27 expression and phosphorylation, indicating a severe situation of stress. HSP-27 can interact with different intracellular signaling pathways. Propranolol and SL-327 were able to antagonize the activation of hypothalamic-pituitary adrenal (HPA) axis and the phosphorylation of HSP-27 observed during morphine withdrawal. Therefore, β-adrenergic receptors and the extracellular signal-regulated kinase (ERK) pathway would be involved in HPA axis activity, and consequently, in HSP-27 activation. Finally, selective blockade of corticotrophin releasing factor (CRF)-1 receptor and the genetic deletion of CRF1 receptors antagonize cardiac adaptive changes. These changes are increased noradrenaline (NA) turnover, HPA axis activation and decreased HSP-27 expression and phosphorylation. This suggests a link between the HPA axis and HSP-27. On the other hand, morphine withdrawal increases µ-calpain expression, which in turn degrades cardiac troponin T (cTnT). This fact, together with a co-localization between cTnT and HSP-27, suggests that this chaperone avoids the degradation of cTnT by µ-calpain, correcting the cardiac contractility abnormalities observed during addictive processes. The aim of our research is to review the possible role of HSP-27 in the cardiac changes observed during morphine withdrawal and to understand the mechanisms implicated in its cardiac protective functions.

Identifiants

pubmed: 32455528
pii: ijms21103623
doi: 10.3390/ijms21103623
pmc: PMC7279295
pii:
doi:

Substances chimiques

HSP27 Heat-Shock Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministerio de Ciencia e Innovación
ID : SAF/FEDER 2017-85679-R
Organisme : Fundación Séneca
ID : 20847/PI/18

Références

Mol Cell Endocrinol. 2010 Aug 30;325(1-2):1-7
pubmed: 20416357
Annu Rev Genet. 1988;22:631-77
pubmed: 2853609
Biochem J. 1995 May 15;308 ( Pt 1):57-61
pubmed: 7755588
J Biol Chem. 1999 Jul 2;274(27):18947-56
pubmed: 10383393
Eur J Pharmacol. 2008 Apr 7;583(2-3):215-25
pubmed: 18342852
J Forensic Sci. 2011 May;56(3):645-8
pubmed: 21361943
Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1108-12
pubmed: 7755719
Am J Psychiatry. 2007 Aug;164(8):1149-59
pubmed: 17671276
Cell Stress Chaperones. 2007 Winter;12(4):364-72
pubmed: 18229455
BMC Biochem. 2005 Mar 11;6:4
pubmed: 15760475
Basic Res Cardiol. 2011 May;106(3):473-83
pubmed: 21287352
Mol Cell Biochem. 1996 Mar 9;156(1):1-8
pubmed: 8709970
Neuropsychopharmacology. 2006 Mar;31(3):675-84
pubmed: 16395295
Expert Opin Investig Drugs. 2004 Jul;13(7):799-828
pubmed: 15212620
Neuroscience. 2003;118(2):379-86
pubmed: 12699774
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2969-73
pubmed: 7708757
Expert Opin Ther Targets. 2007 Nov;11(11):1401-13
pubmed: 18028006
Regul Pept. 1995 Jan 26;55(2):149-54
pubmed: 7754102
Circulation. 1992 Dec;86(6):1671-91
pubmed: 1451239
J Cardiovasc Pharmacol. 2002 Sep;40(3):363-9
pubmed: 12198322
Curr Probl Surg. 1994 Aug;31(8):658-720
pubmed: 8045159
Mol Psychiatry. 2002;7(9):967-74
pubmed: 12399950
J Biol Chem. 2013 Sep 6;288(36):26335-26349
pubmed: 23897817
J Pharmacol Exp Ther. 2012 Sep;342(3):665-75
pubmed: 22647273
Nature. 1954 May 22;173(4412):973-6
pubmed: 13165698
Endocrinology. 1993 Mar;132(3):1063-70
pubmed: 8095012
J Clin Endocrinol Metab. 2002 Jan;87(1):340-6
pubmed: 11788672
Neuropsychopharmacology. 2005 Jan;30(1):90-8
pubmed: 15138444
Am J Physiol Cell Physiol. 2019 Nov 1;317(5):C910-C921
pubmed: 31411917
Free Radic Biol Med. 2018 Feb 1;115:166-178
pubmed: 29191461
J Mol Cell Cardiol. 2019 Sep;134:86-97
pubmed: 31302117
PLoS One. 2013;8(2):e55867
pubmed: 23409070
Curr Mol Med. 2009 Sep;9(7):863-72
pubmed: 19860665
Naunyn Schmiedebergs Arch Pharmacol. 2001 Sep;364(3):193-8
pubmed: 11521160
Naunyn Schmiedebergs Arch Pharmacol. 2018 Apr;391(4):423-434
pubmed: 29383398
Rev Physiol Biochem Pharmacol. 2004;151:1-44
pubmed: 14740253
Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9873-7
pubmed: 1658790
J Mol Cell Cardiol. 2006 Jun;40(6):761-74
pubmed: 16678850
Am J Physiol Heart Circ Physiol. 2016 Feb 1;310(3):H376-84
pubmed: 26637561
Circ Res. 1999 Jan 8-22;84(1):9-20
pubmed: 9915770
Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):404-13
pubmed: 15706087
J Mol Cell Cardiol. 2010 Sep;49(3):370-9
pubmed: 20600103
Oncogene. 2000 Oct 5;19(42):4855-63
pubmed: 11039903
Cardiovasc J Afr. 2009 Jan-Feb;20(1):43-51
pubmed: 19287816
Basic Res Cardiol. 2009 Jul;104(4):366-76
pubmed: 19104749
Life Sci. 2019 Mar 1;220:50-57
pubmed: 30708098
Eur J Pharmacol. 2010 Apr 25;632(1-3):1-6
pubmed: 20132811
J Biol Chem. 1992 Apr 15;267(11):7718-25
pubmed: 1560006
Cardiovasc Res. 2008 Aug 1;79(3):500-8
pubmed: 18397962
Basic Res Cardiol. 2004 Nov;99(6):392-4
pubmed: 15309411
Heart Dis. 2003 Jul-Aug;5(4):253-71
pubmed: 12877759
Can J Cardiol. 2012 Mar-Apr;28(2 Suppl):S7-19
pubmed: 22424286
Biochemistry. 2006 Sep 26;45(38):11681-94
pubmed: 16981728
Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1746-53
pubmed: 16731654
Am J Med Genet B Neuropsychiatr Genet. 2004 Aug 15;129B(1):120-4
pubmed: 15274053
Basic Res Cardiol. 2008 Sep;103(5):454-63
pubmed: 18500486
CNS Neurol Disord Drug Targets. 2012 May;11(3):306-23
pubmed: 22483300
J Biol Chem. 2011 Sep 16;286(37):32170-7
pubmed: 21795695
Ann N Y Acad Sci. 2002 Jun;965:487-96
pubmed: 12105124
Br J Anaesth. 1997 Apr;78(4):439-41
pubmed: 9135345
Microsc Res Tech. 2003 Jun 15;61(3):315-23
pubmed: 12768547
J Mol Cell Cardiol. 2011 Jul;51(1):129-39
pubmed: 21530534
Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H314-26
pubmed: 18487434
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6252-6
pubmed: 11972044
Br J Pharmacol. 2008 Sep;155(1):73-83
pubmed: 18536752
J Mol Cell Cardiol. 2007 May;42(5):972-80
pubmed: 17407780
J Cell Mol Med. 2015 Feb;19(2):340-50
pubmed: 25331547
Biochem J. 2005 Nov 15;392(Pt 1):145-52
pubmed: 16050811
PLoS One. 2015 Oct 28;10(10):e0141502
pubmed: 26509576
Br J Pharmacol. 2014 Feb;171(3):688-700
pubmed: 24490859
Circulation. 2001 Feb 13;103(6):850-5
pubmed: 11171794
Biochem Biophys Res Commun. 2000 Apr 2;270(1):183-9
pubmed: 10733925
J Mol Cell Cardiol. 2008 Jan;44(1):59-68
pubmed: 18068185
Eur J Pharmacol. 2015 Nov 5;766:142-50
pubmed: 26452515
Br J Anaesth. 1996 Jan;76(1):106-10
pubmed: 8672350
Toxicol Appl Pharmacol. 2014 Feb 15;275(1):28-35
pubmed: 24398105
Basic Res Cardiol. 2007 Jul;102(4):341-9
pubmed: 17450314
Biol Psychiatry. 1999 Nov 1;46(9):1167-80
pubmed: 10560023
Cardiovasc Res. 2001 Sep;51(4):637-46
pubmed: 11530097
J Biol Chem. 2004 Mar 12;279(11):10252-60
pubmed: 14662766
J Biol Chem. 2007 Jun 8;282(23):17297-305
pubmed: 17439945
Cell. 1993 Jul 16;74(1):1-4
pubmed: 8334697
Eur J Pharmacol. 2008 Apr 7;583(2-3):350-7
pubmed: 18272149
Biochem Biophys Res Commun. 1997 Dec 8;241(1):187-92
pubmed: 9405255
Eur J Pharmacol. 2004 Mar 8;487(1-3):117-24
pubmed: 15033383
Ann N Y Acad Sci. 2008 Dec;1148:118-26
pubmed: 19120099
Biochim Biophys Acta. 2008 Jul-Aug;1778(7-8):1653-64
pubmed: 18371297

Auteurs

Elena Martínez-Laorden (E)

Department of Pharmacology, Faculty of Medicine, University of Murcia, 30100 Murcia, Spain.

Javier Navarro-Zaragoza (J)

Department of Pharmacology, Faculty of Medicine, University of Murcia, 30100 Murcia, Spain.

María Victoria Milanés (MV)

Department of Pharmacology, Faculty of Medicine, University of Murcia, 30100 Murcia, Spain.

María Luisa Laorden (ML)

Department of Pharmacology, Faculty of Medicine, University of Murcia, 30100 Murcia, Spain.

Pilar Almela (P)

Department of Pharmacology, Faculty of Medicine, University of Murcia, 30100 Murcia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH